Truist(TFC)

Search documents
Truist reports fourth quarter 2024 results
Prnewswire· 2025-01-17 11:00
Earnings Report and Access - Truist Financial Corporation reported its fourth quarter 2024 results on January 17, 2025 [1] - The earnings call was scheduled for 8 a m ET on the same day, accessible via webcast or dial-in [1] - The earnings release, investor presentation, and detailed financial schedules are available on Truist's Investor Relations website [1] - A replay of the call will be available on the website for 30 days [1] Company Overview - Truist Financial Corporation is a purpose-driven financial services company focused on inspiring and building better lives and communities [2] - The company is a leading U S commercial bank with a strong market share in high-growth markets across the country [2] - Truist offers a wide range of products and services, including consumer and small business banking, commercial banking, corporate and investment banking, wealth management, payments, and specialized lending [2] - Headquartered in Charlotte, North Carolina, Truist is a top-10 commercial bank with total assets of $531 billion as of December 31, 2024 [2] Webcast and Dial-in Information - The webcast for the earnings call can be accessed at app webinar net/xOqjwYK80mY [3] - The dial-in number for the earnings call is 1-877-883-0383 with passcode 7041380 [3]
Sirona Biochem Showcases TFC-1326 in Stonegate Healthcare's Landmark Report
GlobeNewswire News Room· 2025-01-15 18:21
Company Overview - Sirona Biochem is a cosmetic ingredient and drug discovery company with a proprietary platform technology specializing in stabilizing carbohydrate molecules to improve efficacy and safety [2] - The company's compounds are patented and licensed to leading global companies, generating revenue through licensing fees, milestone fees, and ongoing royalty payments [2] - Sirona's laboratory, TFChem, is located in France and has received multiple French national scientific awards and EU/French government grants [2] Product Innovation - TFC-1326, Sirona's anti-aging compound, delivers rapid, consistent results with potent antioxidant and anti-inflammatory benefits [3] - Unlike traditional retinoids, TFC-1326 is suitable for all skin types, including sensitive skin, without causing irritation [3] - The compound has been highlighted in Stonegate Healthcare Partners' research report, which evaluates its clinical trial performance compared to traditional retinoid treatments [7] Market Impact - TFC-1326 is positioned as a disruptive force in the $12.5 billion global anti-aging market, offering a highly effective and user-friendly alternative to conventional treatments [3][4] - The publication of Stonegate Healthcare's report underscores the transformative potential of TFC-1326 in redefining skincare science [4] Industry Recognition - Stonegate Healthcare's analysis highlights TFC-1326's ability to significantly reduce wrinkle depth and volume, enhance skin elasticity and firmness, and ensure deep hydration [1][3] - The recognition by Stonegate Healthcare reflects Sirona Biochem's commitment to pioneering advanced solutions in the skincare industry [4]
Truist Foundation partners with Center for Disaster Philanthropy to provide over $20M in disaster recovery grants in Western North Carolina
Prnewswire· 2025-01-15 14:00
Grants will support post-Hurricane Helene housing and small business recovery, long-term resiliencyCHARLOTTE, N.C., Jan. 15, 2025 /PRNewswire/ -- Truist Foundation today announced it will partner with Center for Disaster Philanthropy to provide over $20 million in disaster recovery grants in Western North Carolina as part of the Truist Cares for Western North Carolina initiative. Flooding in the aftermath of Hurricane Helene, which hit in September 2024, destroyed or damaged more than 250,000 homes across 3 ...
Higher NII to Aid Truist's Q4 Earnings, Lower Fee Income to Hurt
ZACKS· 2025-01-14 17:46
Truist Financial (TFC) is scheduled to announce its fourth-quarter and full-year 2024 results on Jan. 17 before the opening bell. Given the implementation of rate cuts, the overall lending scenario improved in the quarter.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Per the Federal Reserve’s latest data, demand for commercial and industrial (C&I) loans (accounting for roughly 50% of TFC’s total loans and leases held for investment) rose during the fourth quarter. Likewise, consum ...
Insights Into Truist Financial (TFC) Q4: Wall Street Projections for Key Metrics
ZACKS· 2025-01-14 15:16
Wall Street analysts forecast that Truist Financial Corporation (TFC) will report quarterly earnings of $0.87 per share in its upcoming release, pointing to a year-over-year increase of 7.4%. It is anticipated that revenues will amount to $5 billion, exhibiting a decline of 12.3% compared to the year-ago quarter.The current level reflects an upward revision of 0.2% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively rea ...
Truist Financial Corporation (TFC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ZACKS· 2025-01-10 16:01
The market expects Truist Financial Corporation (TFC) to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expect ...
Truist announces fourth-quarter 2024 earnings call details
Prnewswire· 2024-12-20 14:17
CHARLOTTE, N.C., Dec. 20, 2024 /PRNewswire/ -- Truist Financial Corporation (NYSE: TFC) will report fourth-quarter 2024 financial results before the market opens on Friday, January 17, 2025. Chairman and Chief Executive Officer Bill Rogers and Chief Financial Officer Mike Maguire will host a conference call to review the company's financial results at 8 a.m. ET.Investors can access the live earnings call by webcast or dial-in as follows:Live webcast for listeners: https://app.webinar.net/xOqjwYK80mYDial-in ...
Truist receives 'Outstanding' Community Reinvestment Act rating
Prnewswire· 2024-12-11 13:00
CHARLOTTE, N.C., Dec. 11, 2024 /PRNewswire/ -- Truist Financial Corporation (NYSE: TFC) today announced it received the highest possible overall rating of "Outstanding" from the Federal Deposit Insurance Corporation for its most recent Community Reinvestment Act examination period, from 2020-2022. The CRA encourages banks to help meet the credit needs of communities in which they operate, including low- and moderate-income (LMI) neighborhoods, consistent with safe and sound banking operations."Receiving an ...
Truist to speak at the Goldman Sachs US Financial Services Conference
Prnewswire· 2024-11-21 14:00
CHARLOTTE, N.C., Nov. 21, 2024 /PRNewswire/ -- Truist Financial Corporation (NYSE: TFC) today announced that Chairman and Chief Executive Officer Bill Rogers will speak at the Goldman Sachs 2024 US Financial Services Conference at 10:40 a.m. ET on Tuesday, Dec. 10, 2024, in New York City.A live audio webcast will be available on the day of the conference at ir.truist.com under Events & Presentations. A replay of the webcast will be available on the website for 30 days.About TruistTruist Financial Corporatio ...
Sirona Biochem Announces Publication of Groundbreaking Study on TFC-1326 Compound in the Journal of Cosmetic Dermatology
GlobeNewswire News Room· 2024-11-20 21:30
VANCOUVER, British Columbia, Nov. 20, 2024 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) is proud to announce the publication of a pivotal research article in the prestigious Journal of Cosmetic Dermatology. About the Study The article, titled “TFC-1326 Compound Reduces Clinical Signs of Skin Aging: Evidence From In Vitro Human Adipose and Skin Models and Pilot Clinical Trial,” highlights the groundbreaking efficacy of Sirona’s proprietary compound TFC-1326 in reducing visible signs of sk ...